2025
|
Invention
|
Treatment and prevention of nephrotoxin-induced kidney injuries.
The invention provides for Comp... |
2024
|
Invention
|
Cyclophilin inhibitors and uses thereof.
Compounds defined by Formula 4 are used as cyclophilin ... |
|
Invention
|
Cyclophilin inhibitors and uses thereof. Compounds as defined by Formulas 1-6 and uses thereof fo... |
|
Invention
|
Treatment and prevention of agent‐induced liver conditions or diseases. Provided herein is Compou... |
2022
|
Invention
|
Cyclophilin inhibitors and uses thereof. Compounds defined by Formula 4 are used as cyclophilin i... |
2021
|
Invention
|
Prevention and treatment of organ injuries.
The invention provides for Compound I or a pharmaceu... |
|
Invention
|
Prevention and treatment of organ injuries. The invention provides for Compound I or a pharmaceut... |
|
Invention
|
Cyclophilin inhibitors and uses thereof.
Provided are compounds as defined by Formula 1 and uses... |
|
Invention
|
Preparation of cyclosporin derivatives.
The invention provides a process for the preparation of ... |
|
Invention
|
Cyclophilin inhibitors and uses thereof. Provided are compounds as defined by Formula 1 and uses ... |
|
Invention
|
Preparation of cyclosporin derivatives. The invention provides a process for the preparation of c... |
2020
|
Invention
|
Treatment and prevention of nephrotoxin-induced kidney injuries. Provided herein is Compound I or... |
|
Invention
|
Cyclosporin analog and use thereof.
The present invention provides a cyclosporin analog and use ... |
|
Invention
|
Cyclosporin analog and use thereof. 121412355 heteroalkyl ring. |